Fox vs Sirius XM
FOXA and SIRI side by side, both in communications. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How FOXA and SIRI compare
Fox is the larger company, worth 2.7 times as much as Sirius XM ($26.5B against $9.8B).
On earnings, Sirius XM is cheaper: it trades at 11.9× trailing earnings, against 16.5× for Fox.
Fox grew revenue faster over the last twelve months (5.1% versus 0.51% for Sirius XM).
Both pay dividends: Fox yields 0.90% and Sirius XM 3.7%.
Sirius XM scores higher on the StockData Score (14 against 7 for Fox), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | FOXA | SIRI |
|---|---|---|
| Size and price | ||
| Market cap | $26.5B | $9.8B |
| Share price | $63.24 | $29.01 |
| Change, 1 year | 4.0% | 37.7% |
| Change, 5 years | 52.5% | −54.7% |
| Beta (5Y) | 0.56 | 1.06 |
| Employees | 11K | 5,119 |
| StockData Score | ||
| Total score | 7 | 14 (better) |
| Valuation score | 0 | 6 (better) |
| Growth score | 2 | 2 |
| Performance score | 0 | 4 (better) |
| Health score | 3 (better) | 1 |
| Dividend score | 2 (better) | 1 |
| Valuation | ||
| P/E | 16.5× | 11.9× (better) |
| P/S | 1.5× | 1.1× (better) |
| P/B | 2.3× | 0.8× (better) |
| EV/EBITDA | 9.4× | 8.9× (better) |
| P/FCF | 18.1× | 6.2× (better) |
| PEG | 0.91 | – |
| FCF yield | 5.5% | 16.2% (better) |
| Fair value | $60.63 | $43.39 |
| Margin of safety | −4.3% | 33.1% (better) |
| Growth | ||
| Revenue growth (TTM) | 5.1% (better) | 0.51% |
| Revenue growth, 5Y average | 5.8% (better) | 1.3% |
| Net income growth (TTM) | – | −9.4% |
| EPS growth (TTM) | −21.8% | −14.1% (better) |
| EPS growth, 5Y average | 1.2% | 45.7% (better) |
| Profitability | ||
| Gross margin | – | 52.9% |
| Operating margin | – | 19.0% |
| Net margin | – | 10.5% |
| FCF margin | 8.6% | 18.4% (better) |
| Return on equity | – | 7.6% |
| Return on invested capital | – | 5.8% |
| Financial health | ||
| Debt / equity | 0.57 (better) | 0.77 |
| Net debt / EBITDA | 0.78 (better) | 4.28 |
| Interest coverage | – | 3.7× |
| Current ratio | 3.17 (better) | 0.32 |
| Altman Z-score | 2.83 (better) | 1.42 |
| Piotroski F-score | – | 6 |
| Dividends and buybacks | ||
| Dividend yield | 0.90% | 3.7% (better) |
| Buyback yield | 7.5% (better) | 1.1% |
| Shareholder yield | 8.4% (better) | 4.8% |
| Ownership | ||
| Held by institutions | 95.2% | 85.5% |
| Held by insiders | 33.1% | 7.9% |
| Insider net buying, 12 months | −$110M | −$1.3M (better) |
| Superinvestors holding | 2 | 4 (better) |
| Short interest, % of float | – | 12.1% |
Go deeper
- FOXA stock overview
- FOXA income statement
- FOXA valuation and score
- SIRI stock overview
- SIRI income statement
- SIRI valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.